US 12,715,900 · Application 17/793,601 · Granted Aug 25, 2026
US 12,715,900
Preparation method for semaglutide
Estimated expiration
December 7, 2042
16y 93d remaining
- Could not fetch continuity data for application PCTCN2020101081: Resource not found (404)
Earliest effective filing
Jul 9, 2020
+ 20 years
Jul 9, 2040
PTA +881d
Dec 7, 2042
No TD
—
Final
Dec 7, 2042
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- July 18, 2022
- Earliest effective filing
- July 9, 2020
- Issue date
- August 25, 2026
- PTA
- +881 days
- Base expiry (before PTA)
- July 9, 2040
July 9, 2020 + 20 years = July 9, 2040 + 881 PTA days = December 7, 2042
- National stage entry of application PCTCN2020101081, filed Jul 9, 2020
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/793,601 · US 12,715,900
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,715,900: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12715900Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.